Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study.

ABSTRACT:

SUBMITTER: Li YY 

PROVIDER: S-EPMC10796351 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature